JHS Svendgaard Laboratories Limited (JHS.BO)
INR 13.61
(1.95%)
INR 13.61
(1.95%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 33.77 Million INR | -117.68% |
| 2022 | -163.81 Million INR | -35.93% |
| 2021 | 28.65 Million INR | -34.34% |
| 2020 | 94.56 Million INR | -18.03% |
| 2019 | 48.7 Million INR | 91.76% |
| 2018 | 60.29 Million INR | -55.65% |
| 2017 | 143.45 Million INR | 50.75% |
| 2016 | 121.11 Million INR | 71.53% |
| 2015 | -108.01 Million INR | 411.14% |
| 2014 | -96.14 Million INR | -29.03% |
| 2013 | -17.41 Million INR | -159.35% |
| 2012 | 117.96 Million INR | -81.69% |
| 2011 | 160.18 Million INR | 266.75% |
| 2010 | -96.06 Million INR | -159.88% |
| 2009 | 160.41 Million INR | 117.51% |
| 2008 | 73.75 Million INR | -15.52% |
| 2007 | 69.93 Million INR | 32.17% |
| 2006 | 66.04 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 19.68 Million INR | 3.54% |
| 2023 Q2 | 6.01 Million INR | 135.7% |
| 2023 Q1 | -16.86 Million INR | -133.97% |
| 2023 FY | - INR | -117.68% |
| 2023 Q4 | 8.36 Million INR | 1529.23% |
| 2023 Q3 | -585 Thousand INR | -109.72% |
| 2022 FY | - INR | -35.93% |
| 2022 Q1 | 194 Thousand INR | -99.01% |
| 2022 Q2 | 5.49 Million INR | 2730.93% |
| 2022 Q3 | -1.66 Million INR | -130.37% |
| 2022 Q4 | 49.62 Million INR | 3075.3% |
| 2021 Q3 | 16.05 Million INR | -43.28% |
| 2021 Q2 | 28.29 Million INR | 50.58% |
| 2021 FY | - INR | -34.34% |
| 2021 Q1 | 18.79 Million INR | -57.7% |
| 2021 Q4 | 19.58 Million INR | 22.03% |
| 2020 Q2 | 33.95 Million INR | 454.35% |
| 2020 Q1 | -9.58 Million INR | -110.38% |
| 2020 FY | - INR | -18.03% |
| 2020 Q4 | 44.42 Million INR | 71.97% |
| 2020 Q3 | 25.83 Million INR | -23.91% |
| 2019 FY | - INR | 91.76% |
| 2019 Q1 | 15.43 Million INR | -35.21% |
| 2019 Q2 | 18.14 Million INR | 17.55% |
| 2019 Q4 | 92.27 Million INR | 231.32% |
| 2019 Q3 | 27.85 Million INR | 53.53% |
| 2018 Q4 | 23.81 Million INR | -29.39% |
| 2018 Q1 | 12.4 Million INR | -79.57% |
| 2018 FY | - INR | -55.65% |
| 2018 Q3 | 33.73 Million INR | 230.79% |
| 2018 Q2 | 10.19 Million INR | -17.81% |
| 2017 Q3 | 60.94 Million INR | 36.33% |
| 2017 FY | - INR | 50.75% |
| 2017 Q4 | 60.71 Million INR | -0.38% |
| 2017 Q2 | 44.7 Million INR | 113.42% |
| 2017 Q1 | 20.94 Million INR | -39.04% |
| 2016 FY | - INR | 71.53% |
| 2016 Q4 | 34.36 Million INR | -3.94% |
| 2016 Q1 | 19.89 Million INR | -28.01% |
| 2016 Q2 | 31.18 Million INR | 56.78% |
| 2016 Q3 | 35.77 Million INR | 14.7% |
| 2015 Q1 | 13.41 Million INR | 258.06% |
| 2015 FY | - INR | 411.14% |
| 2015 Q4 | 27.63 Million INR | 140.45% |
| 2015 Q2 | 19.04 Million INR | 41.96% |
| 2015 Q3 | 11.49 Million INR | -39.66% |
| 2014 Q3 | 689 Thousand INR | 105.79% |
| 2014 Q1 | -15.36 Million INR | -146.87% |
| 2014 FY | - INR | -29.03% |
| 2014 Q4 | 3.74 Million INR | 443.76% |
| 2014 Q2 | -11.9 Million INR | 22.5% |
| 2013 Q3 | -10.9 Million INR | 36.7% |
| 2013 FY | - INR | -159.35% |
| 2013 Q1 | 2.59 Million INR | -85.44% |
| 2013 Q2 | -17.22 Million INR | -763.27% |
| 2013 Q4 | 32.77 Million INR | 400.65% |
| 2012 Q1 | 95.85 Million INR | 0.0% |
| 2012 Q4 | 17.83 Million INR | -35.35% |
| 2012 Q2 | 38.01 Million INR | -60.34% |
| 2012 Q3 | 27.59 Million INR | -27.43% |
| 2012 FY | - INR | -81.69% |
| 2011 FY | - INR | 266.75% |
| 2010 FY | - INR | -159.88% |
| 2009 FY | - INR | 117.51% |
| 2008 FY | - INR | -15.52% |
| 2007 FY | - INR | 32.17% |
| 2006 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ador Multiproducts Limited | -24.81 Million INR | 236.125% |
| Ambica Agarbathies Aroma & Industries Limited | 98.85 Million INR | 65.832% |
| Bajaj Consumer Care Limited | 1.99 Billion INR | 98.311% |
| Colgate-Palmolive (India) Limited | 19.57 Billion INR | 99.827% |
| Cupid Limited | 501.01 Million INR | 93.258% |
| Dabur India Limited | 28.81 Billion INR | 99.883% |
| Emami Limited | 9.9 Billion INR | 99.659% |
| Gillette India Limited | 6.27 Billion INR | 99.462% |
| Godrej Consumer Products Limited | 7.23 Billion INR | 99.533% |
| Hindustan Unilever Limited | 152.56 Billion INR | 99.978% |
| Hipolin Limited | -7.05 Million INR | 578.888% |
| Honasa Consumer Limited | 1.86 Billion INR | 98.192% |
| Jyothy Labs Limited | 5.33 Billion INR | 99.367% |
| Kaya Limited | -233.46 Million INR | 114.468% |
| Marico Limited | 21.67 Billion INR | 99.844% |
| N.K Industries Limited | 19.9 Million INR | -69.712% |
| PAOS INDUSTRIES LIMITED | 1000.00 INR | -3377500.0% |
| Paramount Cosmetics (India) Limited | 4.5 Million INR | -650.578% |
| Pee Cee Cosma Sope Limited | 159.57 Million INR | 78.834% |
| Procter & Gamble Hygiene and Health Care Limited | 9.83 Billion INR | 99.656% |